Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.
about
Treatment Outcome of Patients with Buruli Ulcer Disease in Togo.Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease-Towards a Point-of-Care Test.Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.A Community Based Study on the Mode of Transmission, Prevention and Treatment of Buruli Ulcers in Southwest Cameroon: Knowledge, Attitude and PracticesAnalysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.New Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles.BCG and protection against inflammatory and auto-immune diseases.Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region.Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.Molecular detection of Mycobacterium ulcerans in the environment and its relationship with Buruli ulcer occurrence in Zio and Yoto districts of maritime region in Togo.BCG and Adverse Events in the Context of Leprosy.IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection
P2860
Q35810457-1350260C-918F-4938-AA0A-8E3695518468Q35840888-36135AE0-0C89-49DC-9F02-13D15D2B6BFAQ35915755-7D5CDCED-B2B4-408D-8C03-6C53740CB811Q36030070-5B868B85-3880-4F06-B10A-3FCEED491E0AQ36291527-869ACD5A-63BB-454F-8115-08787FFB6E07Q37445202-BE505728-C9A1-492C-B21D-3B149C02A51BQ40203403-2CBDFD7B-384E-4677-8A87-6D0C15AEC3F6Q47709186-0CA8665F-97CD-44EA-9EDB-41FDCA237C98Q52657152-6F82D27A-55B6-4408-92E0-A0995EFE0119Q54204356-E9EA2B0F-38CD-47CD-928C-91146D98E93FQ55264893-53CA183E-92CC-4332-8AE9-A8027B57450EQ58880192-5B642D29-CD55-4943-8D56-314BC19D4F90
P2860
Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@ast
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@en
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@nl
type
label
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@ast
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@en
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@nl
prefLabel
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@ast
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@en
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@nl
P2093
P2860
P50
P1476
Effectiveness of routine BCG v ...... blic of Congo, Ghana and Togo.
@en
P2093
Abass Mohammed Kabiru
Abiba Banla Kere
Adjaho Koba
Basile Kobara
Bawimodom Bidjada
Bernhard Fleischer
Delphin Mavinga Phanzu
Ebekalisai Piten
Elysée Kalundieko Luzolo
Franz Xaver Wiedemann
P2860
P356
10.1371/JOURNAL.PNTD.0003457
P407
P577
2015-01-08T00:00:00Z